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Abstract
Aquaculture facilities worldwide continue to experi-
ence significant economic losses because of disease
caused by pathogenic bacteria, including multidrug-
resistant strains. This scenario drives the search for
alternative methods to inactivate pathogenic bacteria.
Phage therapy is currently considered as a viable
alternative to antibiotics for inactivation of bacterial
pathogens in aquaculture systems. While phage
therapy appears to represent a useful and flexible tool
for microbiological decontamination of aquaculture
effluents, the effect of physical and chemical proper-
ties of culture waters on the efficiency of this tech-
nology has never been reported. The present study
aimed to evaluate the effect of physical and chemical
properties of aquaculture waters (e.g. pH, tempera-
ture, salinity and organic matter content) on the
efficiency of phage therapy under controlled experi-
mental conditions in order to provide a basis for the
selection of the most suitable protocol for subse-
quent experiments. A bioluminescent genetically
transformed Escherichia coli was selected as a
model microorganism to monitor real-time phage
therapy kinetics through the measurement of
bioluminescence, thus avoiding the laborious and
time-consuming conventional method of counting
colony-forming units (CFU). For all experiments, a
bacterial concentration of ≈ 105 CFU ml−1 and a phage
concentration of ≈ 106–8 plaque forming unit ml−1 were
used. Phage survival was not significantly affected
by the natural variability of pH (6.5–7.4), temperature
(10–25°C), salinity (0–30 g NaCl l−1) and organic
matter concentration of aquaculture waters in a tem-
perate climate. Nonetheless, the efficiency of phage
therapy was mostly affected by the variation of salin-
ity and organic matter content. As the effectiveness of
phage therapy increases with water salt content, this
approach appears to be a suitable choice for marine
aquaculture systems. The success of phage therapy
may also be enhanced in non-marine systems
through the addition of salt, whenever this option is
feasible and does not affect the survival of aquatic
species being cultured.
Introduction
Nearly one-third of the world seafood supply comes from
aquaculture, the fastest growing food animal-producing
sector worldwide (FAO, 2012). Modern aquaculture,
however, often suffers from heavy financial losses
because of mass mortality caused by bacterial infection,
including those promoted by multidrug-resistant bacteria
that are easily transmitted through the water and therefore
able to infect a great variety of aquaculture species
(Almeida et al., 2009).
In order to prevent possible diseases in aquaculture,
producers often use antibiotics. Nonetheless, this practice
is currently discouraged and kept to a minimum in order
to avoid the development of drug-resistant bacteria. To
overcome the risks of development and spreading of
antibiotic-resistant bacteria, it is urgent to develop more
environmentally friendly methods to control disease in
aquaculture. In line with this idea, the use of phage
therapy seems to be a very promising technique, as bac-
terial diseases are a major problem in the expanding
aquaculture industry (Wahli et al., 2002; Berthe, 2005;
Almeida et al., 2009).
Bacteriophages (commonly termed phages) are bacte-
rial viruses that are extremely abundant in nature and are
believed to be important in controlling bacterial popula-
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tions in natural systems (Abedon, 2008), even those
known to be multidrug-resistant (Biswas et al., 2002;
Matsuzaki et al., 2003; Wills et al., 2005). The use of
phages to control bacterial infections in aquatic environ-
ments, such as fish diseases, has already been demon-
strated in several studies (Nakai et al., 1999; Nakai and
Park, 2002; Imbeault et al., 2006; Vinod et al., 2006;
Karunasagar et al., 2007; Skurnik et al., 2007). Phage
therapy has also been suggested as a useful approach to
control pathogenic bacteria in cultured oyster (Park and
Nakai, 2003) and more generally to treat bacterial infec-
tions in cultured shellfish (Berthe, 2005), but no reports on
bivalve shellfish bacterial control (BC) by phages are cur-
rently available. As the host fish and shellfish live in an
aqueous media, the therapeutic phage can have a con-
tinuous and physiologically close contact with target
pathogens in a natural arrangement.
The use of phage therapy requires the understanding of
kinetic phenomena unknown in conventional treatments.
The kinetic theory indicates that the time of phage appli-
cation (Nakai and Park, 2002), applied concentration of
bacteria and phages, i.e. the multiplicity of infection (MOI)
(Cairns et al., 2009), and phage survival in culture water
of fish farming plants (Nakai et al., 1999; Pereira et al.,
2011), can be critical. It has been shown that a higher
protective effect can be promoted by bacteriophages
when these are used to control bacteria at an early stage
of infection, i.e. phages are simultaneously applied with
the bacteria (Nakai and Park, 2002), and an increase in
pathogenic bacteria reduction in parallel to that of the MOI
(Pasharawipas et al., 2011; Prasad et al., 2011) or a
sooner bacterial reduction at higher MOI (Hsu et al.,
2000). Pereira and colleagues (2011) showed that the
pattern of survival of phages infecting important aquacul-
ture pathogenic bacteria is different in culture waters. An
Aeromonas salmonicida phage survived in fish-farm
water during 90 days. In contrast, the abundance of Vibrio
parahaemolyticus phage strongly decreased during the
incubation period, showing a survival time frame of 16
days (Pereira et al., 2011). Nakai and colleagues (1999)
showed that anti-Lactococcus garvieae phages persisted
well in different values of temperature (5–37°C) and salin-
ity (0–70 NaCl g l−1) but not in low pH values (3.5, contrary
to 6–8).
It has been shown that phage therapy may represent
a very useful and flexible tool for the disinfection of
aquaculture-farming polluted waters and that time of
phage addition, MOI, viral survival and viability are impor-
tant factors (Almeida et al., 2009). However, the effect of
physical and chemical properties of aquaculture waters
on the efficiency of this approach has never been reported
yet. This can be an important aspect to consider, namely
if phage therapy would be applied to semi-intensive
marine earth ponds in temperate climates, a culture tech-
nique widely employed throughout the world, because in
these systems, environmental parameters can shift sig-
nificantly through the year. While Nakai and colleagues
(1999) tested the survival of L. garvieae phages in various
physical and chemical (water temperature, salinity, pH)
conditions, they did not study the effect of the various
conditions on the efficiency of phage therapy.
The objective of this study was to evaluate the effect of
physical and chemical properties of aquaculture waters,
such as pH, temperature, salinity and organic matter
content, on the efficiency of phage therapy under con-
trolled experimental conditions. The kinetics of phage-
bacteria interactions was examined in vitro in order to
determine the course of the infection and provide a
basis for the selection of the most suitable protocol
for subsequent experiments in aquaculture systems. A
bioluminescent-transformed bacterium Escherichia coli
(Alves et al., 2008) was used as model to follow the phage
therapy process in real-time conditions, avoiding the labo-
rious and time-consuming conventional methods of serial
dilutions, plating, overnight incubation and counting of
colony forming units (CFUs).
Results
Phage identification
The phage was identified as a T4-like phage with 95% of
homology with the Enterobacteriaceae phage vB_EcoM-
VR7 (accession number HM563683). The nucleotide
sequence of the phage was deposited in the GenBank
database under accession no. KC755108.
Correlation between bioluminescence and CFUs
It was observed a linear correlation between viable counts
and the bioluminescence signal of overnight cultures of
the bioluminescent recombinant E. coli (Fig. 1).
Phage therapy assays
MOI experiments. At a MOI of 1, the maximum of bacte-
rium inactivation was 3.3 log, achieved after 24 h of
phage therapy. Increasing the MOI to a value of 10 did not
significantly increase the rate of inactivation (3 log) after
the same period of time [analysis of variance (ANOVA),
P > 0.05]. At higher values of MOI (100 and 1000), it was
shown that the rate of inactivation slightly increases with
the MOI, with maximum values of 3.2 log for a MOI of 100
and 3.7 log of reduction at a MOI of 1000, respectively,
after 18 and 12 h of phage therapy. After 24 h, the rate of
inactivation was about 3 log for both MOI of 100 and 1000
(Fig. 2A). However, this increase in the rate of inactivation
with higher MOI values was not statistically significant
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when compared with the MOI of 1 and 10 (ANOVA,
P > 0.05). The maximum difference between the different
MOI values was of 0.7 log, which corresponds to an
increase of 9% in the efficiency of phage therapy
(Table 1).
Bacterial density in the BCs increased by 1.5 log
(ANOVA, P < 0.05) during the first 18–20 h of incubation
(Fig. 2A). After this time, the bacterial density remained
constant until the end of the experiment (ANOVA,
P > 0.05). The differences in bacterial concentration
between different MOI values were not significant
(ANOVA, P > 0.05).
No decrease of the phage survival was observed during
the 72 h of the experiments for the phage alone and for
the phage in the presence of its host (Fig. 2B). While the
phage control (PC) remained constant during all time
(ANOVA, P > 0.05), when the phage was incubated in the
presence of its host, a significant increase (ANOVA,
P < 0.05) of 3.4 log was observed for the MOI of 1
(ANOVA, P < 0.05). Increasing the MOI to 10, 100 and
1000 revealed a shorter increase on phage survival
(about 2 log). Although having similar rates of survival,
there is a significant difference between the MOI values of
10 and 1000 (ANOVA, P < 0.05), while the others are not
statistically different (ANOVA, P > 0.05) (Fig. 2B).
pH experiments. When different pH values were tested,
it was observed that the rate of inactivation slightly
10
8
6
4
2
0
0–1 1 2 3 4
Log Bioluminescence (RLU)
y = 1.0546x + 1.8055
R2 = 0.9971
5 6 7 8
Lo
g 
U
F
C
 m
l–
1
Fig. 1. Relationship between the bioluminescence signal and
viable counts of an overnight culture of a transformed biolumines-
cent E. coli (∼ 109 CFU ml−1) serially diluted in PBS. Biolumines-
cence is expressed in RLUs and viable counts in CFU ml−1. Values
represent the mean of three independent experiments; error bars
indicate the standard deviation.
Fig. 2. Inactivation of bioluminescent E. coli by the phages at different MOI values. (A), bacterial bioluminescence and (B) phage concentra-
tion variation along the 72 h experiment. Values represent the mean of three independent experiments; error bars indicate the standard devia-
tion. BC, bacteria control; BP, bacteria plus phage; PC, phage control.
Table 1. Maximum reduction obtained after phage therapy of the
bioluminescent E. coli for each of the tested condition.
Parameter
Maximum Reduction
Time
HoursLog %
MOI
1 3.3 66.3 24
10 3.0 64.1 24
100 3.2 67.6 18
1000 3.7 73.1 12
pH
6.5 4.6 81.2 24
7.0 3.9 77.7 24
7.4 3.2 67.6 18
Temperature (°C)
15 4.3 65.0 18
20 4.5 60.0 18
25 3.2 67,6 18
Salinity (g NaCl l−1)
0 3.4 50.0 18
10 4.4 65.9 10
20 5.2 90.0 12
30 5.4 91.6 10
Organic matter
TSB 1× 3.2 67.6 18
TSB 0.5× 4.2 78.5 24
TSB 2× 5.1 96.6 24
PBS 2.8 46.3 10
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decreased with the increase of the pH; however, the dif-
ferences among the three values of pH were not statisti-
cally significant (ANOVA, P > 0.05). At a pH of 6.5, the
phage inactivated the bioluminescent E. coli by a
maximum of 4.6 log after 24 h of incubation. At higher pH
values, the maximum rate of inactivation was 3.9 and
3.2 log, achieved after 24 and 18 h of incubation, respec-
tively, at a pH of 7.0 and 7.4. After 24 h, the inactivation
was still 3.2 log for the pH of 7.4 (Fig. 3A). The maximum
difference between phage inactivation at different pH
values was 1.4 log, which corresponds to an increase of
14% in the efficiency of phage therapy (Table 1).
The bacterial density in the BC at a pH of 7.4 increased
by 1.4 log (ANOVA, P < 0.05) during the first 24 h of incu-
bation, reaching a plateau by this time (Fig. 3A). At pH
values of 6.5 and 7.0, the bacterial density decreased by
0.7 log (ANOVA, P < 0.05) during the first 8 h of incuba-
tion. After this time, the bacterial density increased, after
18 h of incubation, to similar values (ANOVA, P > 0.05) to
those observed for BC at a pH of 7.4, exceeding even the
values of the BC at a pH 7.4 after 24 h (Fig. 3A).
During the time course of the experiments, no decrease
on phage survival was observed for the phage in the
presence of its host and for the phage alone (Fig. 3B).
However, while the PC without bacteria was maintained
almost constant throughout the experiment (ANOVA,
P > 0.05), when the phage was incubated in the presence
of its host, an increase of 1.5 log was observed for a pH
value of 6.5. The values at a pH of 7.0 increased to
1.2 log, and they were found to be statistically different
from those obtained at 6.5 (ANOVA, P < 0.05). The
highest pH value (7.4) was the one that showed the
highest increase in the rate of survival, with values of
about 2 log, and it was statistically different only from
pH 7.0 (ANOVA, P < 0.05) (Fig. 3B).
Temperature experiments. The rate of E. coli inactivation
was higher at 15 and 20°C than at 25°C (ANOVA,
P < 0.05). A maximum decrease of 4.3 log was observed
after 18 h when the samples were kept at a temperature
of 15°C. When the temperature was increased to 20°C,
the rate of maximum inactivation slightly increased to
4.5 log after the same time of incubation. However, the
difference between these two temperatures was not sta-
tistically significant (ANOVA, P > 0.05). At a temperature
of 25°C, the maximum rate of inactivation significantly
decreased (ANOVA, P < 0.05) to 3.2 log after 18 h of incu-
bation (Fig. 4A and C). The maximum difference between
phage inactivation at 120 and 25°C was of 1.3 log, which
corresponds to an increase of 8% in the efficiency of
phage therapy (Table 1).
Bacterial density in the BC incubated at 25°C increased
by 1.3 log (ANOVA, P < 0.05) during the first 18–24 h
of incubation (Fig. 3C). From this moment on, bacterial
density remained constant until the end of the experiment
(ANOVA, P > 0.05). At 15 and 20°C, it also increased
during the first 18–20 h of incubation, the increase being
higher at 20°C (ANOVA, P > 0.05) but reaching similar
values (ANOVA, P > 0.05) after 36 h of incubation
(Fig. 3A).
Phage survival was maintained relatively constant
during the time course of the experiments (ANOVA,
P > 0.05), when the phage was tested alone (Fig. 4B).
However, when the phage was incubated in the presence
of its host, an increase of 0.4 log was observed when the
phage was incubated at 15°C (ANOVA, P < 0.05). At
higher temperatures (20 and 25°C), the rate of survival
increased up to 1.3 log for 20°C and 1.9 log for 25°C.
However, the difference between these two temperature
values was not statistically significant (ANOVA, P > 0.05)
(Fig. 4B and D).
Fig. 3. Inactivation of bioluminescent E. coli by the phage at different pH values. (A), bacterial bioluminescence and (B) phage concentration
variation along the 72 h experiment. Values represent the mean of three independent experiments; error bars indicate the standard deviation.
BC, bacteria control; BP, bacteria plus phage; PC, phage control.
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Salinity experiments. At 0 g NaCl g l−1, the maximum rate
of inactivation was of 3.2 log after 18 h of incubation. At
10 g NaCl l−1, the maximum rate of inactivation was
4.4 log after 10 h of incubation. After 18 h of incubation
the rate of inactivation was reduced, although not signifi-
cantly, to 4 log (ANOVA, P > 0.05) but was found to be
significantly different from that obtained at 0 NaCl g l−1 at
the same time (ANOVA, P < 0.05). Increasing the salinity
to 20 g NaCl l−1 also increased the rate of inactivation to a
maximum value of 5.2 log after 12 h of incubation. After
18 h, the rate of inactivation was about 4.7 log and
was significantly different from that obtained at 10 g
NaCl l−1 at this time (ANOVA, P < 0.05). At 30 g NaCl l−1,
the maximum inactivation achieved was 5.4 log after 10 h
of incubation. After 18 h, the rate of inactivation was
reduced to 4.1 log, but that reduction was not statistically
significant (ANOVA, P > 0.05) and was also not signifi-
cantly different from that obtained at 20 g NaCl l−1 at the
same time (ANOVA, P > 0.05). The maximum difference
between phage inactivation between 0 and 30 g NaCl l−1
was of 2.2 log, which corresponds to an increase of 24%
in the efficiency of phage therapy (Table 1).
Bacterial density in the BC at 0 and 10 g NaCl l−1
increased approximately 1 log (ANOVA, P < 0.05) during
the first 18 h of incubation (Fig. 5A and C). After this time,
the bacterial density remained constant until the end of
the experiment. In the controls at 20 and 30 g NaCl l−1,
bacterial density decreased by 0.65 and 1 log, respec-
tively, during the first 4 h (Fig. 5C). The number of bacteria
increased after 24 h, reaching values similar to those of
BC at 0 and 10 g NaCl l−1 (ANOVA, P > 0.05).
During the 72 h of the experiments, phage survival
was maintained relatively constant when the phage was
tested without its host (ANOVA, P > 0.05) (Fig. 5B and D).
However, when the phage was incubated in the presence
of its host, an increase of about 2 log was observed for a
salinity value of 0 g l−1, which was found to be statistically
different from all the other salinity values (ANOVA,
P < 0.05) (Fig. 5B). At 10 g l−1, the increase on phage
multiplication was higher (2.5 log) than that obtained at a
salinity value of 20 g l−1 (about 1 log) and was statistically
different from that observed at 30 g l−1 (ANOVA, P < 0.05)
(Fig. 5D).
Organic matter experiments. When the effect of the
organic matter concentration was evaluated [Tryptic Soy
Broth medium (TSB)0.5×, TSB1×, TSB2×], it was shown
that a higher amount of organic matter increases the rate
of inactivation. When the assays were done with a normal
TSB (TSB1×) growth culture medium concentration, the
highest inactivation was 3.2 log and was achieved after
18 h of phage therapy and was not significantly different
Fig. 4. Inactivation of bioluminescent E. coli by the phage at different temperature values. (A) bacterial concentration at 15 and 20°C, (B)
phage concentration at 15 and 20°C, (C) bacterial bioluminescence at 25°C, and (D) phage concentration variation along the 72 h experiment
at 25°C. Values represent the mean of three independent experiments; error bars indicate the standard deviation. BC, bacteria control; BP,
bacteria plus phage; PC, phage control.
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from that observed after 24 h (ANOVA, P > 0.05). When
the concentration of TSB was reduced to 50% (TSB0.5×),
the maximum rate of inactivation was 4.2 log but occurred
later in time (after 24 h of phage therapy) (ANOVA,
P > 0,05). After 18 h, the rate of inactivation was also not
statistically significant from that obtained at TSB1×
(ANOVA, P > 0.05) and reached a value of 3.4 log. Using
TSB with double concentration (TSB2×), the rate of inac-
tivation reached a maximum of 5.1 log after 24 h of phage
therapy (ANOVA, P < 0.05). After 18 h, however, the dif-
ference between TSB with double concentration and
regular TSB was not significant (ANOVA, P > 0.05), and
the rate of inactivation was about 3.4 log (Fig. 6A). When
the phage therapy assays were conducted solely in the
presence of phosphate buffer saline (PBS) (maximum
reduction of the organic matter content), there was still a
considerable bacterium reduction (maximum of inactiva-
tion 2.8 log) observed after 10 h of phage therapy. After
18 h of treatment, the rate of inactivation was slightly
reduced to 2.5 log. When compared with other samples
with higher organic matter content, the rate of E. coli
inactivation recorded for the phage was the lowest one
(ANOVA, P < 0.05) (Fig. 6C). The maximum difference
between phage inactivation under rich nutrient conditions
(TSB2×) and poor nutrient condition (PBS) was of 2.8 log,
which corresponds to an increase of about 50% in the
efficiency of phage therapy (Table 1).
Bacterial density in the BC in TSB1× increased by
1.4 log (ANOVA, P < 0.05) during the first 24 h of incuba-
tion (Figs. 6A). After this time, the bacterial density
remained constant until the end of the experiment
(ANOVA, P > 0.05). When the TSB was used at 2× and
0.5×, the number of bacteria increased more slowly that
when used at 1×, reaching the same values of the BC at
1× (ANOVA, P > 0.05) (Figs. 6A). After 24 h of incubation,
bacteria in the BC in TSB2× increased by 1 log reaching a
plateaux thereafter. Contrarily, after 24 h of incubation, the
bacteria in the BC in TSB0.5× decreased by 0.9 log until
36 h, maintained (ANOVA, P > 0.05) the bacterial concen-
tration after that (Figs. 6A). The number of bacteria incu-
bated in PBS was constant during the incubation period
(Figs. 6A).
No significant decrease of phage survival was observed
during the 72 h of the experiment for PCs tested without
its host (ANOVA, P > 0.05). However, when the phage
was incubated in the presence of its host, the rate of
phage survival increased for about 2 log after 72 h for the
experiments performed on TSB1×. When TSB2× was
used, an increase of 2.6 log was observed after 72 h.
However, it was found not to be statistically different from
Fig. 5. Inactivation of bioluminescent E. coli by the phage at different salinity values. (A), bacterial bioluminescence at salinity 0 g l−1, (B)
phage concentration variation at salinity 0 g l−1, (C), bacterial concentration variation at salinities 10, 20 and 30 g l−1, and (D) phage concentra-
tion variation at salinities 10, 20 and 30 g l−1, along the 72 h experiment. Values represent the mean of three independent experiments; error
bars indicate the standard deviation. BC, bacteria control; BP, bacteria plus phage; PC, phage control.
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the values obtained at TSB1× (ANOVA, P > 0.05). Reduc-
ing the concentration to 50% (TSB0.5×), or when the
assays were performed on PBS, produced only a moder-
ate increase on phage survival of about 1 log, which
was found to be not statistically different for both of them
(ANOVA, P > 0.05) but different from those obtained with
TSB1× and TSB2× (ANOVA, P < 0.05) (Fig. 6B).
Prophage detection in the host after phage therapy
No plaques were observed after the addition of mitomycin
C to the mixture of bacteria and phages, indicating that
lysogeny did not occur.
Host resistance detection after phage therapy
After incubation in the presence of phages, host bacteria
did not show resistance to phage infection. All isolated
colonies collected after 120 h of phage application at an
MOI of 100 were sensitive to the phage and showed a
clear zone of lysis on Tryptic Soy Agar medium (TSA).
Discussion
Considering that in outdoor facilities aquaculture water is
exposed to natural shifts in physical and chemical param-
eters, thorough investigations addressing different field
conditions are required for the design and implementation
of effective phage therapy protocols.
The kinetic theory of phage therapy predicts that the
MOI could be critical to the bacterial inactivation effi-
ciency. However, there are limited data available on
phage effective doses in aquaculture applications. Con-
sequently, before determining the effect of the environ-
mental factors in the efficiency of phage therapy, it is
necessary to determine the best MOI to be used. It has
been shown, both in vitro and in vivo, that the reduction
of pathogenic bacteria increases in parallel with MOI
(Pasharawipas et al., 2011; Prasad et al., 2011) or that
bacterial reduction occurs sooner at higher MOI values
(Hsu et al., 2000). In treated catfish Clarias batrachus
serum samples with 4.6 × 106 plaque forming unit
(PFU) ml−1 and with 9.1 × 106 PFU ml−1 of a lytic phage
specific to Flavobacterium columnare, bacterial abun-
dance was reduced, respectively, by 3 log (58.4%) and
5 log (73.8%) after 96 h, when the animals were chal-
lenged with the same bacterial concentration (Prasad
et al., 2011). A V. harveyi phage, isolated from a shrimp
pond contaminated with V. harveyi, resulted in the
inactivation of all V. harveyi at an MOI of 20, while an MOI
value of 1 resulted in a significant survival of V. harveyi
(Pasharawipas et al., 2011). The addition of specific
phages of Aeromonas hydrophyla, at a MOI higher than
11.5, to a pure bacterial culture of A. hydrophyla reduced
Fig. 6. Inactivation of bioluminescent E. coli by the phage at different organic matter concentrations. (A), bacterial bioluminescence in TSB,
(B) phage concentration variation in TSB, (C) variation of bacterial concentration in PBS and (D) variation of phage concentration in PBS,
throughout the 72 h experiment. Values represent the mean of three independent experiments; error bars indicate the standard deviation.
BC, bacteria control; BP, bacteria plus phage; PC, phage control.
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the host concentration by three orders of magnitude after
2 h. The addition of the same phage, at a MOI of 0.23, to
A. hydrophyla challenged pond water of Japanese eel
Anguilla japonica reduced the host by two orders of mag-
nitude but only after 8 h (Hsu et al., 2000). In the present
study, the increase in MOI from 1 to 1000 did not promote
a significant increase in the efficiency of phage therapy.
While the maximum inactivation occurred sooner in time,
bacterial inactivation at a MOI of 1000 was not signifi-
cantly higher when compared with that observed for the
other MOI values. As proposed by Nakai (2010) and con-
trarily to the case of chemicals and other substances,
precise initial doses may not be essential in aquaculture
because of the self-perpetuating nature of phages
revealed by an increasing of phage titres along with bac-
teria in infected fish or in contaminated waters. As already
referred, the number of phages incubated for 12 h in the
presence of the host was similar for an initial MOI of 1 and
1000. Moreover, it has been reported that even if the initial
number of phages is lower than that of the bacteria, the
number of phages after incubation in the presence of their
host exceeded that of bacteria after several generations
and that the bacterial population are still controlled (Hsu
et al., 2000; Henriques et al., 2013). Accordingly, in this
study, an intermediate MOI value of 100 was chosen to
determine the effect of environmental factors in the effi-
ciency of phage therapy.
Results show that although phage survival is not sig-
nificantly affected by the natural variability of environmen-
tal parameters in aquaculture waters from temperate
climates, the efficiency of phage therapy can be affected
by variations on these parameters, namely water salinity
and organic matter content.
It has been shown that factors such as temperature, pH
and salinity play important roles on the survival of phages
(Wu and Chao, 1987; Nakai et al., 1999; Pirisi, 2000;
Leverentz et al., 2001; Cerveny et al., 2002; Jepson and
March, 2004; Srinivasan et al., 2007). However, taking
into account that in aquaculture waters, the variation of
these parameters is moderate, these physical and chemi-
cal parameters have not been described as factors that
could significantly affect phage survival in field conditions
(Nakai et al., 1999). Nothing is known about the effect of
organic matter content on phage survival; in this study,
phage survival was not significantly affected by the vari-
ation of the organic matter content. Phage survival was
stable under different conditions of pH, temperature,
salinity and organic matter content in the absence of the
host during the time course of experimental trials (72 h)
and also until at least 5 days (data not shown). However,
in the presence of the host, the phage number increased
under all tested conditions, even when phages were
added at initial low concentrations (i.e. MOI of 1) relatively
to the host density.
The pH has been shown to be an important control
factor, influencing attachment, infectivity, intracellular rep-
lication and multiplication of phages. (Pirisi, 2000;
Leverentz et al., 2001; 2004; Jepson and March, 2004).
Generally, studies on the lytic activity of bacteriophages
have shown that pH values less than 5 and over 10 are
less efficient and the optimum pH is around a neutral pH
of 6–8 (Jarrell et al., 1997; Nakai et al., 1999; Pirisi, 2000;
Jepson and March, 2004). A phage capable of infecting a
bacterium attaches to a receptor site on the cell surface
using the phage lysozyme to weaken the bacterial cell
wall. This process is very important for phage infection.
However, pH can interfere with the lysozyme enzyme
and/or with other capsids proteins, thus preventing phage
attachment to receptor sites on the host cell (Leverentz
et al., 2001; 2004). Although most phage proteins are
stable at a somehow neutral pH, in this study, pH values
ranging from 6.5 to 7.4 were tested, as they are included
within the optimum neutral range of pH values; phage
therapy efficiency was not significantly affected, even at
lower pH values, which affected the bacterial growth at
the first hours of incubation.
Much like pH, temperature can also interfere with
phage attachment, thus preventing phages to infect the
host. The stability of the lysozyme increases with lowering
the temperature. For instance, mutant phage T4 lysozyme
shows maximum stability at 12.5°C (Fennema, 1996),
decreasing its stability at temperatures below or above
this value because of denaturation. This could explain
why the phage of E. coli, a T4-like phage, was more
efficient under temperatures of 15–20°C than under 25°C,
when the bacterial growth was lower.
Bacteriophages have a requirement for salts at low
concentrations to be successful during the infection
process and growth (Baross et al., 1978). At low concen-
trations, salt ions interact with proteins and stabilize
protein structure by neutralizing protein charges.
However, at higher concentrations, NaCl increases the
thermal denaturation of the proteins and can also
adversely affect the structural stability of the phage
nucleic acid (Fennema, 1996). In fact, the optimal stable
salinity range of a phage of V. anguillarum isolated from a
fish overwintering pond was 15–45 g l−1 (Wu and Chao,
1987). Cerveny and colleagues (2002) showed that two
different phages were effective against three different
V. vulnificus strains with various degrees of virulence,
while a third phage that required the presence of seawater
to lyse bacteria in vitro was ineffective at treating mice
in the absence of salt. Silva (2005) showed that a
V. parahaemolyticus phage was more salt tolerant than
two V. vulnificus phages. When the V. vulnificus bacterio-
phages were stored at 4°C in salt concentrations of
6–22 and at 30°C in salt concentrations of 6–10 g l−1, they
had retained activity by day 52. The bacteriophage of
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V. parahaemolyticus remained active in salt concentra-
tions of 6–30 at 4°C and in salt concentrations of
6–22 g l−1 at 30°C by day 52. This salt requirement
could explain the results obtained in this study, a higher
bacterial inactivation in the presence of NaCl. E. coli
was inactivated more efficiently in the presence of 10, 20
and 30 g NaCl l−1 than in the absence of NaCl. Although
the presence of 10, 20 and 30 g NaCl l−1 delayed the
bacterial growth during the first hours of incubation, this
delay was not reflected negatively in the phage therapy
efficiency.
The host cell must be in an appropriate physiological
state to allow productive phage infection. It is well known
that bacteria are more susceptible to phage infection in
nutrient-rich conditions (Chibani-Chennoufi et al., 2004).
In the marine environment, as well as in aquaculture
systems, bacteria live with considerable nutrients but not
as high as in culture media; nonetheless, they continue to
replicate phages, maintaining their concentration around
one order of magnitude higher than that of themselves
(Almeida et al., 2001; 2009). In fact, while in the present
study, bacteria were inactivated by phages in a poor nutri-
ent medium (PBS), the efficiency of inactivation was lower
than that observed when rich nutrient media were used
(regular TSB, 0.5× diluted TSB and double concentrated
TSB growth medium).
Although phages can effectively reduce the number of
viable bacteria by 3–5 logs after 12–24 h of incubation,
depending on the experimental conditions, after this
period, some bacteria still remained viable and could
regrowth, as observed in most of in vitro phage therapy
studies (Pereira et al., 2011; Vieira et al., 2012). However,
the bacterial population may have decreased to a level
low enough to be eliminated by the host immune system,
such as fish in the case of aquaculture application. As
demonstrated by the mathematical model proposed by
Levin and Bull (2004), the combination of phage and host
defences has the potential to keep bacterial density below
a lethal threshold. In fact, the results of several studies
using animal models showed that animal mortality and/or
disease symptoms are significantly lower than those
observed in challenged non-treated animals and even
than those that occur naturally (non-challenged and non-
treated animals) (Nakai et al., 1999; Hsu et al., 2000;
Leverentz et al., 2001; Park and Nakai, 2003; Wills et al.,
2005; Srinivasan et al., 2007; Prasad et al., 2011;
Henriques et al., 2013). According to the literature, surviv-
ing bacteria may be due to the reduced probability of
viruses to find host bacteria (Bull et al., 2002; Levin and
Bull, 2004), a non-replicating condition of surviving bac-
teria that is physiologically refractory to phage infection
(Bull et al., 2002), lysogenic conversion (Skurnik and
Strauch, 2006) and to the development of phage resist-
ance by the bacterial host (Levin and Bull, 2004).
The hypothesis of bacteria restart growth due to the low
probability of an encounter between viruses and host
bacteria is not likely, as the increase of MOI of 1–1000 did
not increase the efficiency of phage therapy. The hypoth-
esis of non-replicating bacteria to be physiologically
refractory to phage infection is also unlikely because fol-
lowing the peak of bacterial inactivation by phages, the
remaining bacteria grew at a high rate and reached den-
sities similar to those observed for controls. The occur-
rence of lysogeny, which can also render the bacterium
immune to not only the original phages but also to related
phages (Skurnik and Strauch, 2006), could also explain
bacterial regrowth. Nonetheless, no evidence of lysogeny
was observed during phage therapy experiments.
However, it is important to highlight that only a single test
(induction by mitomycin C) was used to evaluate the
occurrence of lysogenic conversion, and more rigorous
testing is needed to exclude this possibility. The results of
this study suggest that bacteria that restarted to grow after
phage therapy were not resistant to the phage. Similar
results have been observed in other studies (Sillankorva
et al., 2004; Oliveira et al., 2009). However, with the
approach used in this study, bacteria that restarted
growing after phage therapy regained sensitivity to
phages only after three streak-plating steps on solid
medium. This means that these bacteria were still infected
with viruses, which prevented their infection by new
phages. More specific tests, such as searching for modi-
fications in bacterial phage receptors, are needed to
evaluate the development of resistance and explain the
presence of viable bacteria after phage therapy.
It has been suggested that phage-resistant variants of
virulent bacteria would not be pathogenic (Anonymous,
1983). Bacterial cell surface components that act as
receptors for phage attachment can undergo mutation
when bacteria develop resistance to phages. As some of
the surface components can also act as virulence factors,
the mutated bacteria would not be any more pathogenic.
This could explain why viable bacteria remained after
phage therapy in vitro but do not interfere with the effi-
ciency of phage therapy in vivo. Specific in vitro and in
vivo assays, such as evaluation of virulence factors activ-
ity before and after phage therapy, are needed in order to
confirm this hypothesis.
In a near future, it will be essential to understand how
the interaction of environmental factors influences the
efficiency of phage therapy in aquaculture systems. The
combination of the best conditions of pH, temperature,
salinity and organic matter content can improve the effi-
ciency of phage therapy. This can be possible to apply in
closed recirculated systems, such as intensive and
superintensive fish and shrimp aquaculture, as well as
shellfish depuration. Moreover, it can also be used to
estimate how the seasonal variation of environmental
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properties can affect phage therapy efficiency. It would be
important, for instance, to forecast how winter rains
through the decrease of salinity and increase of nutrient
concentration (e.g. because of the run-off of organic
matter from the margins of earth ponds) can affect the
effectiveness of phage therapy in semi-intensive aquacul-
ture systems with low salinity.
The rapid method for bacterial detection employing a
bioluminescent approach was of great importance to
study phage/bacterium relationships. With this method, it
was possible to evaluate the effect of MOI in phage
therapy efficiency, and it was also possible to monitor the
phage infection process in real time using a faster,
cheaper and much less laborious approach than that of
conventional methods.
Conclusion
It can be concluded that pH, and probably also tempera-
ture (15–25°C), is not likely to affect the success of phage
therapy in aquaculture conditions. On the contrary, salinity
and organic matter content considerably affect the effi-
ciency of the process. While phage inactivation of micro-
organisms in organic matter clear matrices is not as
effective as in rich media, a high inactivation rate was
reached, and a better response could be obtained in
aquaculture waters where organic matter concentration is
considerably higher than in buffer solutions (such as PBS,
maximum reduction of the organic matter content tested).
As the effectiveness of phage therapy increases in the
presence of salt, this approach is an appropriate choice to
apply in marine aquaculture systems and possibly its
success can be increased in other non-marine aquatic
systems if salt can be added to the media.
Experimental procedures
Bacterial strain and growth conditions
The genetically transformed bacterium E. coli Top10 (Alves
et al., 2008) was used as a bioluminescent bacteria model in
order to follow the phage therapy process in real-time condi-
tions. In experimental systems, a strong correlation between
bioluminescence and viable counts can be demonstrated
(Marincs, 2000; Rocchetta et al., 2001; Alves et al., 2008;
2011). Because the optimum light emission conditions for
E. coli in vitro (25°C, pH 7.4 and 0–5 salinity) (Alves et al.,
2008) limits the application of this method for the evaluation
of the impact of some physical and chemical conditions [low
temperature (< 25°C), high pH (> 7.4) and salinity (> 5)] in the
efficiency of phage therapy, for these particular conditions,
the conventional method of CFUs counting was used.
Fresh plate cultures of transformed E. coli were maintained
in solid TSA medium (Merck, Darmstadt, Germany) with
100 mg ml−1 of ampicillin and 25 mg ml−1 of chloramphenicol
at 4°C. Before each assay, one isolated colony was asepti-
cally transferred to 10 ml of TSB medium (Merck) previously
added with both antibiotics and was grown overnight at 26°C
under stirring (120 r.p.m.). Then, an aliquot of this culture
(100 μl) was aseptically transferred to 10 ml of fresh TSB
medium with antibiotics and grown overnight at 26°C to reach
an optical density of 0.700, corresponding to about 108
cells ml−1 and to a relative luminescence unit (RLU) of
approximately 6 log.
Correlation between bioluminescence and CFUs
To evaluate the correlation between CFUs and the biolumi-
nescent signal (in RLUs) of the transformed E. coli strain, the
bacterium was grown under the aforementioned conditions.
The fresh overnight bacterial culture was serially diluted (10−1
to 10−7) in PBS. Non-diluted (100) and diluted aliquots were
pour-plated on TSA medium (1 ml) and, simultaneously, were
read on a luminometer (1 ml) (TD-20/20 Luminometer, Turner
Designs, Inc., Madison, WI, USA) to determine the biolumi-
nescence signal. Three independent experiments were per-
formed, and the results were averaged.
Phage isolation and purification
A water sample collected from the Corte das Freiras aqua-
culture of Ria de Aveiro (Aveiro, Portugal, 40°37′54.94′ N &
8°40′9.76′ W) was filtered through a 0.45 μm pore size
polycarbonate membranes (Millipore, Bedford, MA, USA).
The filtrate was added to double-concentrated TSB medium
with 1 ml of a fresh culture of the bioluminescent transformed
E. coli. The mixture was incubated at room temperature for
18 h at 80 r.p.m. and then filtered through a 0.2 μm mem-
brane (Millipore). Chloroform at a final concentration of 1%
was added to the supernatant. The titre of the supernatant
was determined by the double-layer agar method using TSA
as culture medium. The plates were incubated at 25°C and
examined for the presence of lysis plaques after 12 h.
Three successive single-plaque isolations were performed
to obtain a pure phage stock. All lysates were centrifuged at
10.000 g during 10 min at 4°C to remove intact bacteria or
bacterial debris. The phage stock was stored at 4°C and was
added of 1% chloroform.
Phage identification
The extraction of nucleic acid from phage particles was
conducted as described by Griffiths et al. (2000). Extrac-
tions were performed by the addition of 0.5 ml of
hexadecyltrimethylammonium bromide extraction buffer and
0.5 ml of phenol-chloroform-isoamyl alcohol (25:24:1;
pH 8.0) to each sample. Samples were lysed for 30 s in a
FastPrep FP120 (BIO 101/Savant) at a speed of 5.5 ms−1,
and the aqueous phase containing nucleic acids was sepa-
rated by centrifugation (16000 g) for 5 min at 4°C. The
aqueous phase was extracted, and phenol was removed by
mixing with an equal volume of chloroform-isoamyl alcohol
followed by repeated centrifugation (16000 g) for 5 min at
4°C. Total nucleic acids were subsequently precipitated from
the extracted aqueous layer with two volumes of 30% (wt/v)
polyethelene glycol – 1.6 M NaCl for 2 h at room tempera-
ture, followed by centrifugation (18000 g) at 4°C for 10 min.
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Pelleted nucleic acids were washed in ice-cold 70% (v/v)
ethanol and air-dried prior to resuspension in 30 ml of Tris-
EDTA (TE) buffer [10 mM Tris HCl, 1 mM ethylenediamine
tetraacetic acid, pH 8.0]. The DNA extracted was used to
amplify the central portion of capsid gene 23 using Mzia 1
(5′-TGTTATIGGTATGGTICGICGTGCTAT-3′) and CAP8 (5′-
TGAAGTTACCTTCACCACGACCGG-3′). The reaction was
carried in a Multigene Gradient Thermal Cycler from MIDSCI
(Valley Park, MO, USA). A reaction mixture of 25 μl was
prepared containing 2 × Dream Taq™ PCR master mix
(10 × Dream Taq™ buffer, 2 μM dNTP mix and 1.25 U Dream
Taq™ polymerase), 4% (v/v) bovine serum albumin (Sigma
Chemical, St. Louis, MO, USA), 0.1 μM primers synthesized
by IBA (Louvain-la-Neuve, Belgium) and template DNA (ca.
10 ng). After 5 min of denaturation at 95°C, 28 thermal cycles
of 45 s at 94°C, 45 s at 56°C and 1.3 min at 72°C were
carried out. A final extension step at 72°C for 10 min was
performed to finish the reaction. PCR products were checked
using standard agarose gel electrophoresis (0.8% agarose,
1× Tris-Acetato-EDTA (TAE) buffer; 100 V for 40 min) and red
gel staining. PCR products were used as templates in the
sequencing reaction that were carried out in an ABI PRISM–
BigDye-Terminator v1.1 (Applied Biosystems, Foster City,
CA, USA), using reverse primer CAP8.
Phage therapy assays
The efficiency of bacterial inactivation by phages, for all
tested conditions at each time, was determined by comparing
the results (CFU ml−1 or RLU ml−1) obtained in the experi-
ments with the bacterial culture in the presence of phages
(test samples) with the results obtained in the BC experi-
ments (bacterial culture without phages) that was incubated
in the same conditions of the test samples. In this way,
misinterpretation because of the use of two different methods
of bacterial quantification and to the use of less favourable
growth conditions for the bacterium, such as low pH, tem-
perature and organic matter concentration, and high salinity,
was avoided.
Before determining the effect of the environmental factors
(physical and chemical) in the efficiency of phage therapy, it
was determined the best MOI to be used in the phage
therapy experiments. It was tested the MOI of 1, 10, 100
and 1000.
MOI selection experiments. In order to obtain 1, 10, 100
and 1000 MOI, 105 CFU ml−1 of the overnight bioluminescent
E. coli culture and a set of serial dilutions of phage suspen-
sions (105 to 108 PFU ml−1) were inoculated into 100 ml steri-
lized glass Erlenmeyers with TSB medium (final volume
50 ml) and incubated at 25°C without agitation (test
samples). For each MOI, two control samples were included,
the BC and the PC. BC was not inoculated with phages, and
the PC was inoculated with the phage but without bacteria.
Both controls were incubated exactly as the test samples.
Aliquots of test samples and of the bacterial and PCs were
collected after 0, 4, 6, 8, 10, 12, 24, 36, 48, 60 and 72 h of
incubation for host bioluminescence measurement and
phage quantification in the test samples, for host biolumines-
cence measurement in the BC and for phage quantification in
the PC. The host bioluminescence was measured in the
luminometer in quadruplicate. The phage titre was deter-
mined, in duplicate, by the double-agar layer method after an
incubation period of 12 h at 25°C. Three independent experi-
ments were performed for each condition, and the results
were averaged.
Assessment of the effect of physical and chemical
factors. Having into account the annual variability of pH
(6.5–7.5), temperature (13–22°C) and salinity (10–35 g l−1),
the organic matter concentration (0.9–5.6 mg l−1) values in
the aquaculture systems of Ria de Aveiro, and the optimum
light emission conditions for E. coli in vitro (25°C, pH 7.4 and
0–5 salinity), the phage therapy assays were designed to
independently test each of the mentioned parameters. In the
cases (low temperature, high salinity and low organic matter
concentration) that were not possible to evaluate the rate of
bacterial inactivation by the bioluminescent technique, the
bacterial concentration was quantified by the pour-plated
method. Aliquots of 1 ml were serially diluted, plated in dupli-
cate and incubated at 25°C for 24 h. Only one MOI (MOI 100)
was used to evaluate the effect of the different physical and
chemical factors. The general procedure was similar to that
described for MOI selection experiments. For each physical
and chemical factor studied, three independent experiments
were done, and the results were presented as an average
mean.
pH experiments. In order to evaluate the effect of water pH,
overnight cultures of transformed E. coli were added to TSB
medium with pH values of 6.5, 7.0 and 7.4. During these
experiments, the temperature of the samples was kept at
25°C.
Temperature experiments. To evaluate the effect of the
temperature, the samples were kept at constant temperature
(15, 20 and 25°C) in an incubator. The experiments were
performed in TSB medium at pH of 7.4.
Salinity experiments. To assess the effect of the salinity,
TSB medium was added of NaCl with concentrations ranging
from 0 to 30 g l−1 (0–3% of NaCl). During these experiments,
the temperature of the samples was kept at 25°C and the pH
at 7.4.
Organic matter concentration experiments. To evaluate
the effect of the organic matter concentration, phage assays
were performed in PBS, diluted TSB medium (0.5×), TSB (1×
TSB) and in double-concentrated TSB (2× TSB). The experi-
ments were performed at a pH of 7.4 and a temperature of
25°C.
Prophage detection in the host bacteria after
phage therapy
In order to evaluate if the phage was capable of lysogenic
conversion (i.e. has the ability to incorporate its own genome
in the bacterial genome), a test using mitomycin C was
applied. Samples were collected after 120 h of contact with
the host bacteria at an MOI of 100. The samples were stress-
induced with mitomycin C (Sigma Chemical) at a final
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concentration of 1 μg ml−1. Cells with temperate phages
usually result in the release of the phage (after inducing it by
mitomycin C). The samples were incubated overnight at 25°C
and centrifuged (10.000 g, 10 min) (ThermoHeraeus Pico,
Hanau, Germany). The supernatant was checked for the
presence of phages by applying the spot test. The absence of
a clear zone after stress-inducing indicates that bacteria have
no prophages in their genome. Three independent assays
were performed.
Detection of host resistance after phage therapy
A suspension of the phage and of the transformed E. coli at
an MOI of 100 was incubated at 25°C. After 120 h of incuba-
tion, an aliquot was collected and centrifuged at 10.000 g,
10 min. The pellet obtained was suspended in TSB medium
and subcultured five times in TSB medium at 25°C during
12 h in order to remove the phage particles from the bacteria.
To check whether the strain remained sensitive to the phage,
the spot test was performed. Three independent assays were
done.
Statistical analysis
Statistical analysis was performed using Statistical Product
and Service Solutions (SPSS) (SPSS 20.0 for Windows,
SPSS, Inc., Chicago, IL, USA). The existence of significant
differences among the different conditions tested for each
physical and chemical factor and for the different MOI tested
was assessed by one-way ANOVA model with the Bonferroni
post-hoc test. For each situation, the significance of differ-
ences was evaluated by comparing the results obtained in
the test samples after correction with the result obtained for
the correspondent control samples (difference between the
concentration obtained in the control and the concentration
obtained in the test sample) for the different times of each of
the three independent assays. Normal distributions were
assessed by Kolmogorov–Smirnov test and the homogeneity
of variances was assessed by Levene test. A value of
P < 0.05 was considered statistically significant.
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